ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data
暂无分享,去创建一个
Harlan M Krumholz | Jing Li | Lixin Jiang | John A Spertus | H. Krumholz | J. Spertus | Yongfei Wang | Lixin Jiang | F. Masoudi | Xi Li | Jing Li | Yongfei Wang | Frederick A Masoudi | Shuang Hu | Xi Li | Qing Wang | Qing Wang | Shuang Hu | Lixin Jiang
[1] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[2] S. Normand,et al. Comparison of Hospital Risk-Standardized Mortality Rates Calculated by Using In-Hospital and 30-Day Models: An Observational Study With Implications for Hospital Profiling , 2012, Annals of Internal Medicine.
[3] J. Alpert,et al. Universal definition of myocardial infarction. , 2007, European heart journal.
[4] Alan D. Lopez,et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.
[5] A. Omran. The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.
[6] T. Lancet,et al. Chinese doctors are under threat , 2010, The Lancet.
[7] H. Krumholz,et al. Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. , 1998, JAMA.
[8] Taixiang Wu,et al. Danshen (Chinese medicinal herb) preparations for acute myocardial infarction. , 2008, The Cochrane database of systematic reviews.
[9] Harlan M Krumholz,et al. Quality Improvement Efforts and Hospital Performance: Rates of Beta-Blocker Prescription After Acute Myocardial Infarction , 2005, Medical care.
[10] Jan Vojáčeka,et al. Třetí univerzální defi nice infarktu myokardu ( Third universal defi nition of myocardial infarction ) , 2013 .
[11] P. Heuschmann,et al. Supplementary Appendix , 2015 .
[12] Zhu Chen,et al. Launch of the health-care reform plan in China , 2009, The Lancet.
[13] B. Gersh,et al. Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention? , 2013, The Lancet.
[14] 中華人民共和国国家統計局. China statistical yearbook , 1988 .
[15] A. Hall,et al. Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003–2009: National Institute for Cardiovascular Outcomes Research (NICOR) , 2012, Heart.
[16] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.
[17] Qun Liu,et al. [Current clinical practice patterns and outcome for acute coronary syndromes in China: results of BRIG project.]. , 2009, Zhonghua xin xue guan bing za zhi.
[18] J. Messenger,et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. , 2010, Journal of the American College of Cardiology.
[19] S. Normand,et al. Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries: Progress and Continuing Challenges , 2010, Circulation.
[20] Paul Heidenreich,et al. Cardiovascular care facts: a report from the national cardiovascular data registry: 2011. , 2013, Journal of the American College of Cardiology.
[21] G. Lamas,et al. Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2007 .
[22] F. Turnbull,et al. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes , 2007, Heart.
[23] R. West,et al. Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010. , 2012, European heart journal.
[24] H. Krumholz,et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.
[25] Lena Osterhagen,et al. Multiple Imputation For Nonresponse In Surveys , 2016 .
[26] W. Weaver,et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.
[27] I. Ranasinghe,et al. System Barriers to the Evidence-Based Care of Acute Coronary Syndrome Patients in China: Qualitative Analysis , 2014, Circulation. Cardiovascular quality and outcomes.
[28] Christopher E. Buller,et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.
[29] H. Krumholz,et al. The China Patient-Centered Evaluative Assessment of Cardiac Events ( China PEACE ) Retrospective Study of Acute Myocardial Infarction : Study Design , 2013 .
[30] Tim Evans,et al. Tackling the challenges to health equity in China , 2008, The Lancet.
[31] S. Normand,et al. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.
[32] M Egger,et al. Intravenous magnesium for acute myocardial infarction. , 2007, The Cochrane database of systematic reviews.
[33] I. Ranasinghe,et al. Hospital Quality Improvement Initiative for Patients With Acute Coronary Syndromes in China: A Cluster Randomized, Controlled Trial , 2014, Circulation. Cardiovascular quality and outcomes.
[34] P. Marquez,et al. Toward a healthy and harmonious life in China : stemming the rising tide of non-communicable diseases , 2011 .
[35] R. Collins,et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.